The Effects of Vyvanse on the Driving Performance of Young Adults With ADHD: A Randomized, Double-Blind, Placebo-Controlled Study.
Phase of Trial: Phase IV
Latest Information Update: 06 May 2014
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacodynamics
- 17 Oct 2012 Results presented at the 25th Annual Congress of the European College of Neuropsychopharmacology.
- 14 Oct 2012 Primary endpoint 'Reaction-time' has been met.
- 24 May 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History